Valuation: Johnson & Johnson

Capitalization 533B 453B 414B 391B 729B 50,316B 736B 4,914B 1,916B 24,169B 1,999B 1,957B 83,441B P/E ratio 2026 *
23.7x
P/E ratio 2027 * 21.5x
Enterprise value 551B 468B 428B 404B 754B 52,004B 760B 5,079B 1,980B 24,980B 2,066B 2,022B 86,240B EV / Sales 2026 *
5.46x
EV / Sales 2027 * 5.04x
Free-Float
77.09%
Yield 2026 *
2.41%
Yield 2027 * 2.52%
1 day-0.53%
1 week-2.58%
Current month-3.71%
1 month-8.28%
3 months-7.26%
6 months+18.63%
Current year+6.94%
1 week 220.63
Extreme 220.63
227.07
1 month 220.63
Extreme 220.63
242.19
Current year 200.91
Extreme 200.9101
251.71
1 year 146.12
Extreme 146.115
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 109.16
Extreme 109.16
251.71
Manager TitleAgeSince
Chief Executive Officer 63 2022-01-02
Director of Finance/CFO 59 2018-06-30
Chief Tech/Sci/R&D Officer 60 2019-11-04
Director TitleAgeSince
Director/Board Member 62 2013-10-14
Director/Board Member 71 2015-06-08
Chairman 63 2023-01-01
Change 5d. change 1-year change 3-years change Capi.($)
-0.53%-2.58%+43.51%+37.42% 533B
-2.72%-1.54%+29.12%+121.40% 846B
-0.57%-2.44%+9.18%+37.27% 356B
-0.94%-0.97%+22.40%+11.18% 324B
+0.23%-1.24%+30.31%+12.00% 282B
+0.05%-2.19%+24.69%+21.29% 278B
-0.82%-0.70%+46.61%-5.15% 275B
-1.76%+4.42%-34.66%-49.15% 203B
+0.79%+0.57%+24.76%+41.49% 179B
-2.04%-0.24%+35.52%+66.66% 163B
Average -0.83%-0.69%+23.14%+29.44% 343.84B
Weighted average by Cap. -1.10%-1.22%+26.11%+45.29%

Financials

2026 *2027 *
Net sales 101B 85.71B 78.44B 74.03B 138B 9,527B 139B 930B 363B 4,576B 378B 371B 15,800B 107B 91.07B 83.34B 78.66B 147B 10,123B 148B 989B 385B 4,863B 402B 394B 16,788B
Net income 22.05B 18.74B 17.15B 16.18B 30.19B 2,083B 30.45B 203B 79.29B 1,000B 82.73B 80.99B 3,454B 24.34B 20.68B 18.93B 17.87B 33.33B 2,299B 33.62B 225B 87.53B 1,104B 91.33B 89.41B 3,813B
Net Debt 17.88B 15.19B 13.9B 13.12B 24.47B 1,688B 24.69B 165B 64.27B 811B 67.07B 65.66B 2,800B 7.03B 5.98B 5.47B 5.16B 9.63B 664B 9.72B 64.88B 25.29B 319B 26.39B 25.84B 1,102B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
26-05-08 221.32 $ -0.53% 5,550,555
26-05-07 222.51 $ -0.94% 7,269,708
26-05-06 224.62 $ -0.41% 7,982,250
26-05-05 225.55 $ +0.60% 5,556,720
26-05-04 224.20 $ -1.32% 8,215,235
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
221.32USD
Average target price
252.42USD
Spread / Average Target
+14.05%

Quarterly revenue - Rate of surprise